SG Americas Securities’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,761
| Closed | -$485K | – | 2911 |
|
|
2023
Q2 | $485K | Sell |
4,761
-3,797
| -44% | -$387K | ﹤0.01% | 1237 |
|
|
2023
Q1 | $778K | Buy |
8,558
+1,606
| +23% | +$146K | 0.01% | 1236 |
|
|
2022
Q4 | $264K | Sell |
6,952
-1,115
| -14% | -$42.3K | ﹤0.01% | 1816 |
|
|
2022
Q3 | $203K | Sell |
8,067
-909
| -10% | -$22.9K | ﹤0.01% | 2057 |
|
|
2022
Q2 | $273K | Buy |
+8,976
| New | +$273K | ﹤0.01% | 2227 |
|
|
2022
Q1 | – | Sell |
-4,981
| Closed | -$131K | – | 3097 |
|
|
2021
Q4 | $131K | Sell |
4,981
-8,580
| -63% | -$226K | ﹤0.01% | 2621 |
|
|
2021
Q3 | $1.36M | Buy |
13,561
+10,015
| +282% | +$1.01M | 0.01% | 1492 |
|
|
2021
Q2 | $502K | Buy |
3,546
+1,615
| +84% | +$229K | ﹤0.01% | 1758 |
|
|
2021
Q1 | $193K | Sell |
1,931
-8,805
| -82% | -$880K | ﹤0.01% | 2459 |
|
|
2020
Q4 | $1.33M | Buy |
10,736
+2,061
| +24% | +$255K | 0.01% | 1195 |
|
|
2020
Q3 | $845K | Buy |
8,675
+4,971
| +134% | +$484K | 0.01% | 1067 |
|
|
2020
Q2 | $578K | Sell |
3,704
-2,046
| -36% | -$319K | ﹤0.01% | 1667 |
|
|
2020
Q1 | $830K | Buy |
5,750
+3,034
| +112% | +$438K | 0.01% | 1141 |
|
|
2019
Q4 | $555K | Buy |
+2,716
| New | +$555K | 0.01% | 1456 |
|
|
2019
Q3 | – | Sell |
-2,553
| Closed | -$241K | – | 2718 |
|
|
2019
Q2 | $241K | Sell |
2,553
-383
| -13% | -$36.2K | ﹤0.01% | 2003 |
|
|
2019
Q1 | $251K | Sell |
2,936
-121
| -4% | -$10.3K | ﹤0.01% | 2108 |
|
|
2018
Q4 | $171K | Buy |
+3,057
| New | +$171K | ﹤0.01% | 2091 |
|